doi: 10.1016/j.jalz.2009.01.021.
A roadmap for the prevention of dementia II: Leon Thal Symposium 2008
Affiliations
- PMID: 19328434
- PMCID: PMC3959165
- DOI: 10.1016/j.jalz.2009.01.021
Item in Clipboard
A roadmap for the prevention of dementia II: Leon Thal Symposium 2008
Alzheimers Dement.
2009 Mar.
Abstract
This document proposes an array of recommendations for a National Plan of Action to accelerate the discovery and development of therapies to delay or prevent the onset of disabling symptoms of Alzheimer's disease. A number of key scientific and public-policy needs identified in this document will be incorporated by the Alzheimer Study Group into a broader National Alzheimer's Strategic Plan, which will be presented to the 111th Congress and the Obama administration in March 2009. The Alzheimer's Strategic Plan is expected to include additional recommendations for governance, family support, healthcare, and delivery of social services.
Comment in
-
Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." A national registry on aging.Alzheimers Dement. 2009 Mar;5(2):105-7. doi: 10.1016/j.jalz.2009.01.010. Alzheimers Dement. 2009. PMID: 19328436 Free PMC article. No abstract available.
-
Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." Establishing a national biomarker database: utility and incentives.Alzheimers Dement. 2009 Mar;5(2):108-13. doi: 10.1016/j.jalz.2009.01.015. Alzheimers Dement. 2009. PMID: 19328437 No abstract available.
-
Commentary on "A roadmap for the prevention of dementia II. Leon Thal Symposium 2008." The Multidomain Alzheimer Preventive Trial (MAPT): a new approach to the prevention of Alzheimer's disease.Alzheimers Dement. 2009 Mar;5(2):114-21. doi: 10.1016/j.jalz.2009.01.008. Alzheimers Dement. 2009. PMID: 19328438 Clinical Trial.
-
Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Recruitment of participants for Alzheimer's disease clinical trials: the role of trust in caregivers, clinical researchers, regulatory authorities, and industry sponsors.Alzheimers Dement. 2009 Mar;5(2):122-4. doi: 10.1016/j.jalz.2009.01.016. Alzheimers Dement. 2009. PMID: 19328439
-
Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Facilitating Alzheimer's disease drug development in the United States.Alzheimers Dement. 2009 Mar;5(2):125-7. doi: 10.1016/j.jalz.2009.01.005. Alzheimers Dement. 2009. PMID: 19328440 Free PMC article. No abstract available.
-
Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." A national registry to identify a cohort for Alzheimer's disease prevention studies.Alzheimers Dement. 2009 Mar;5(2):128-9. doi: 10.1016/j.jalz.2009.01.018. Alzheimers Dement. 2009. PMID: 19328441 Free PMC article. No abstract available.
-
Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Alzheimer's disease translational research programs at the National Institute on Aging.Alzheimers Dement. 2009 Mar;5(2):130-2. doi: 10.1016/j.jalz.2009.01.014. Alzheimers Dement. 2009. PMID: 19328442 Review. No abstract available.
-
Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Centers of excellence in Alzheimer's disease: it is time to better integrate patient care and clinical research to improve the prevention and treatment of Alzheimer's disease.Alzheimers Dement. 2009 Mar;5(2):133-6. doi: 10.1016/j.jalz.2009.01.006. Alzheimers Dement. 2009. PMID: 19328443
-
Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." "Big Asks": what can be changed to increase and speed progress on Alzheimer's disease research and treatment?Alzheimers Dement. 2009 Mar;5(2):137-9. doi: 10.1016/j.jalz.2009.01.003. Alzheimers Dement. 2009. PMID: 19328444 Free PMC article.
-
Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." A proposal to increase participation in Alzheimer's disease clinical trials.Alzheimers Dement. 2009 Mar;5(2):140-2. doi: 10.1016/j.jalz.2009.01.004. Alzheimers Dement. 2009. PMID: 19328445 No abstract available.
-
Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Rationale and recommendations for first evaluating anti-Alzheimer's disease medications in acute brain injury patients.Alzheimers Dement. 2009 Mar;5(2):143-6. doi: 10.1016/j.jalz.2009.01.013. Alzheimers Dement. 2009. PMID: 19328446 Free PMC article. No abstract available.
-
Commentary on "A roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Who may benefit from disease-modifying studies in Alzheimer's disease?Alzheimers Dement. 2009 Mar;5(2):147-8. doi: 10.1016/j.jalz.2009.01.007. Alzheimers Dement. 2009. PMID: 19328447 No abstract available.
-
Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Primary prevention of dementia in Alzheimer's disease: a perspective from prevention research in cardiovascular disease and stroke.Alzheimers Dement. 2009 Mar;5(2):149-53. doi: 10.1016/j.jalz.2009.01.012. Alzheimers Dement. 2009. PMID: 19328448 No abstract available.
-
Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." Subjective cognitive impairment as an antecedent of Alzheimer's dementia: policy import.Alzheimers Dement. 2009 Mar;5(2):154-6. doi: 10.1016/j.jalz.2009.01.011. Alzheimers Dement. 2009. PMID: 19328449 Free PMC article. No abstract available.
-
Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." Comments from abroad.Alzheimers Dement. 2009 Mar;5(2):157-8. doi: 10.1016/j.jalz.2009.01.009. Alzheimers Dement. 2009. PMID: 19328450 No abstract available.
-
Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Innovations in care that advance Alzheimer's disease drug development.Alzheimers Dement. 2009 Mar;5(2):159-62. doi: 10.1016/j.jalz.2009.01.017. Alzheimers Dement. 2009. PMID: 19328451
-
Commentary on "a roadmap for the prevention of dementia II: Leon Thal symposium 2008." The megacommunity approach to Alzheimer's disease.Alzheimers Dement. 2009 Mar;5(2):163-5. doi: 10.1016/j.jalz.2009.02.002. Alzheimers Dement. 2009. PMID: 19328452
-
Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." Prevention trials in persons at risk for dominantly inherited Alzheimer's disease: opportunities and challenges.Alzheimers Dement. 2009 Mar;5(2):166-71. doi: 10.1016/j.jalz.2008.12.002. Alzheimers Dement. 2009. PMID: 19328453 Free PMC article. Review.
-
Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." A federally funded corporation for the prevention and treatment of cognitive impairment and brain aging.Alzheimers Dement. 2009 Mar;5(2):172-9. doi: 10.1016/j.jalz.2009.01.023. Alzheimers Dement. 2009. PMID: 19328454 Review. No abstract available.
References
-
- Alzheimer's Association. 2008 Alzheimer's Disease Facts and Figures. Alzheimers Dement. 2008;4:110–33. - PubMed
-
- Hebert LE, Beckett LA, Scherr PA, Evans DA. Annual incidence of Alzheimer disease in the United States projected to the years 2000 through 2050. Alzheimer Disease and Associated Disorders. 2001;15:169–73. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
